Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of...
AN2 Therapeutics’ $69 Million Initial Public Offering
Crocs’ $2 Billion Senior Secured Term Loan Facility
Davis Polk advised the joint lead arrangers and the administrative agent and initial lender in the transaction. Crocs, Inc. completed a $2 billion senior secured term loan...
Bumble’s $1.1 Billion Shares Offering
Davis Polk advised the representatives of the several underwriters in the offering while Simpson Thacher advised Bumble Inc. Bumble Inc. announced the approximately $1.1 billion SEC-registered offering...
Roivant Sciences Ltd.’s Merger with Montes Archimedes Acquisition Corp.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
Biogen’s $1.75 Billion Exchange Offer
Davis Polk advised the dealer managers in the deal. Biogen Inc. (Nasdaq: BIIB) announced the commencement of a private offer to exchange any and all of its...
Bumble’s $2.5 Billion Initial Public Offering
Simpson Thacher advised Bumble Inc., while Davis Polk advised the representatives of the several underwriters in the offering. Davis Polk also advised Bumble’s CEO and founder,...